Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
Insiders
28 transactions · 0 open-market buys · 13 open-market sells| Filed | Insider | Role | Transaction | Shares | Price (filed) | Value | Form |
|---|---|---|---|---|---|---|---|
| 21 Sep 2026 | Karen Akinsanya | President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | option exercise · 17 Sep 2026 | 31,599 | $4.34 | $137.13K | 4 |
| 21 Sep 2026 | Karen Akinsanya | President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | open market sale · 17 Sep 2026 | 10,000 | $28 | $280.00K | 4 |
| 21 Sep 2026 | Karen Akinsanya | President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | open market sale · 17 Sep 2026 | 21,599 | $30 | $647.97K | 4 |
| 17 Jul 2026 | Jain Rachit | EVP & CFO | open market sale · 16 Jul 2026 | 875 | $15.59 | $13.64K | 4 |
Source: SEC filings. Information and analytics, not investment advice.